Education
About Us
Working with TipRanks
Follow Us
Tissue Regenix Group PLC (GB:TRX)
LSE:TRX
TRX Stock Chart & Stats
7.25p
-0.40p(-0.68%)
At close: 4:00 PM EST
7.25p
-0.40p(-0.68%)
Day’s Range― - ―
52-Week Range4.77p - 64.00p
Previous CloseN/A
Volume536.00
Average Volume (3M)778.41K
Market Cap
£5.16M
Enterprise Value27.76M
Total Cash (Recent Filing)£3.46M
Total Debt (Recent Filing)£10.47M
Price to Earnings (P/E)―
Beta-0.41
Next Earnings
Jun 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding71,395,640
10 Day Avg. Volume807,890
30 Day Avg. Volume778,414
Financial Highlights & Ratios
PEG Ratio1.27
Price to Book (P/B)1.78
Price to Sales (P/S)1.85
P/FCF Ratio-9.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tissue Regenix News
TRX FAQ
What was Tissue Regenix Group PLC’s price range in the past 12 months?
Tissue Regenix Group PLC lowest share price was 4.77p and its highest was 64.00p in the past 12 months.
What is Tissue Regenix Group PLC’s market cap?
Tissue Regenix Group PLC’s market cap is £5.16M.
When is Tissue Regenix Group PLC’s upcoming earnings report date?
Tissue Regenix Group PLC’s upcoming earnings report date is Jun 04, 2026 which is in 190 days.
How were Tissue Regenix Group PLC’s earnings last quarter?
Tissue Regenix Group PLC released its earnings results on Sep 30, 2025. The company reported -0.01p earnings per share for the quarter, missing the consensus estimate of N/A by -0.01p.
Is Tissue Regenix Group PLC overvalued?
According to Wall Street analysts Tissue Regenix Group PLC’s price is currently Overvalued.
Does Tissue Regenix Group PLC pay dividends?
Tissue Regenix Group PLC does not currently pay dividends.
What is Tissue Regenix Group PLC’s EPS estimate?
Tissue Regenix Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tissue Regenix Group PLC have?
Tissue Regenix Group PLC has 71,395,640 shares outstanding.
What happened to Tissue Regenix Group PLC’s price movement after its last earnings report?
Tissue Regenix Group PLC reported an EPS of -0.01p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -36.905%.
Which hedge fund is a major shareholder of Tissue Regenix Group PLC?
Currently, no hedge funds are holding shares in GB:TRX
Company Description
Tissue Regenix Group PLC
Tissue Regenix (TRX) is a regenerative medicine company focused on developing and commercializing innovative tissue-based products for use in surgical procedures. Operating primarily in the healthcare sector, TRX specializes in advanced wound care and orthopedics, utilizing its proprietary decellularization technology to create durable and biocompatible tissue grafts. The company's core products include soft tissue grafts for wound healing and orthopedic applications, which are designed to enhance patient outcomes and facilitate recovery.
Technical Analysis
Futura Medical
―
ImmuPharma
―
Oxford BioDynamics
―
Sareum Holdings
―
Arecor Therapeutics PLC
―